Connor, Clark & Lunn Investment Management (CC&L)’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ALHC
Connor, Clark & Lunn Investment Management (CC&L)'s ALHC Position: Q2 2026 in Review
Connor, Clark & Lunn Investment Management (CC&L) increased its Alignment Healthcare (ALHC) stake by 225% in Q2 2026, buying an estimated $2.03M and bringing the position to 152,548 shares worth $3.63M. The position accounts for 0.01% of the portfolio, ranked #824.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ALHC in Q1 2023 and has held it in 10 quarters since. The position peaked at $4.29M in Q1 2025. 323 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) held 152,548 shares of Alignment Healthcare worth $3.63M as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) bought 105,620 Alignment Healthcare shares in Q2 2026, an estimated $2.03M.
- Alignment Healthcare made up 0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #824 holding.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Alignment Healthcare in Q1 2023 and has held it in 10 quarters since.
- Connor, Clark & Lunn Investment Management (CC&L)'s Alignment Healthcare position peaked at $4.29M in Q1 2025.
- 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.